| Description |
The European Bioanalysis Forum (EBF) is an organisation comprised of (both Global and EU-based) Pharmaceutical companies with operational activities in EU (27 member companies to date). The Membership shares a common vision to advance our understanding of topical concerns through discussion of scientific, technological and regulatory issues of bioanalytical interest.
After a successful first open symposium in December 2008, EBF is organising their second Open Symposium. Pharma and Biotech companies, CRO’s, academia and instrument vendors are invited to attend this open symposium to exchange ideas and information on topical issues of mutual concern in an atmosphere which facilitates the interactive participation of the attendees. This year the symposium will include sessions on the EMEA draft Guidance on Bioanalysis, Validation and Analytical Challenges of non-standard Matrices and/or biomarkers, Unresolved Issues in Method Validations, Analysis of Proteins/Peptides with MS Techniques, Dried Blood Spots, Feedback from internal EBF Discussions (including Recommendations) and Latest Developments and Current Hot Topics in LBAs in a programme which covers the spectrum from Small to Large Molecules. Experts and world opinion leaders will be invited as keynote speakers.
|
|
